Concepedia

Author

G. Veerman

Erasmus MC Cancer InstituteORCID

Also Known As

G D Marijn Veerman, G Veerman, G. D. Marijn Veerman, G. Veerman, G.D. Marijn Veerman, G.D. Veerman, G.D.M. Veerman, G.D.Marijn Veerman, Geerten Dieuwert Marijn Veerman

70

Publications

2.3K

Citations

21

H-Index

30

Concepts

All Affiliations

Erasmus MC Cancer InstituteErasmus MCVrije Universiteit AmsterdamUniversity of AmsterdamAmsterdam UMC Location Vrije Universiteit Amsterdam
GV

About

G. Veerman is an author at Erasmus MC Cancer Institute specializing in medicine, pharmacology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

11

650

2

Engineering

1

1

37

3

Natural Sciences

1

1

16

4

Biochemistry

1

1

16

5

Biomolecular Engineering

1

1

37

G. Veerman

×

31

Publications

2K

Citations

19

H-Index

YearCitations

Interaction between cisplatin and gemcitabine in vitro and in vivo.

Godefridus J. Peters, Andries M. Bergman, V W Ruiz van Haperen,

PubMed

1995

314

Synergistic interaction between cisplatin and gemcitabine in vitro.

Andries M. Bergman, V W Ruiz van Haperen, G. Veerman,

PubMed

1996

306

Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines

C.J.A. van Moorsel, Herbert M. Pinedo, G. Veerman,

British Journal of Cancer

1999

195

Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines

Andries M. Bergman, Herbert M. Pinedo, Iannis Talianidis,

British Journal of Cancer

2003

166

Schedule-dependent antitumor effect of gemcitabine in in vivo model system.

Boudewijn J.M. Braakhuis, Veronique W.T. Ruiz van Haperen, E. Boven,

PubMed

1995

140

Combination chemotherapy studies with gemcitabine.

C.J.A. van Moorsel, G. Veerman, Andries M. Bergman,

PubMed

1997

90

Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumors

C.J.A. van Moorsel, Judith R. Kroep, Herbert M. Pinedo,

Annals of Oncology

1999

88

Preclinical combination therapy with gemcitabine and mechanisms of resistance.

Godefridus J. Peters, Veronique W.T. Ruiz van Haperen, Andries M. Bergman,

PubMed

1996

83

Scheduling of gemcitabine and cisplatin in Lewis Lung tumour bearing mice

C.J.A. van Moorsel, Herbert M. Pinedo, G. Veerman,

European Journal of Cancer

1999

71

Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.

C.L. van der Wilt, Harold H.J. Backus, Kees Smid,

Data Archiving and Networked Services (DANS)

2001

63

Page 1